Irritable bowel syndrome (IBS) causes gastrointestinal symptoms such as abdominal pain,
bloating, and bowel pattern abnormalities, which compromise patients' daily functioning …

Background Irritable bowel syndrome (IBS) is multifactorial in nature, and a wide range of
therapies is available to manage symptoms of this common disorder. Aim To provide an …

Introduction: Diarrhea-predominant irritable bowel syndrome (IBS-D) affects about one-third
of patients with IBS, which is observed in about 12% of people across five continents. The …

Introduction: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal
disorders with a 9–23% prevalence estimated in the general population. Patients can be …

Introduction Irritable bowel syndrome (IBS) is a symptom-based disorder of chronic
abdominal pain and altered bowel habits. The pathogenesis of IBS is multifactorial, leading …

Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …

Irritable bowel syndrome with diarrhea (IBS-D) is a common, chronic functional
gastrointestinal disorder with symptoms that can be distressing for patients and often result …

The irritable bowel syndrome (IBS) is a symptom-based disorder defined by the presence of
abdominal pain and altered bowel habits. 1 Clinical presentations of IBS are diverse, with …

Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by abdominal
pain and alterations in stool form and/or frequency, leading to reduced quality of life …

What is known and Objective: The complexity and diversity of irritable bowel syndrome's
(IBS) presentation make treatment difficult. Although there are reviews and guidelines for …